CLDX: Celldex Therapeutics Inc

22.08 USD 0.30 (1.34%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

CLDX exchange rate has changed by -1.34% for today. During the day, the instrument was traded at a low of 21.71 and at a high of 23.02.

Follow Celldex Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

CLDX News

19:45 Celldex: Despite Dropping Eosinophilic Esophagitis Program, Barzolvolimab On Track (CLDX)
14:22 Why Is Celldex Therapeutics Stock Falling Today - Celldex Therapeutics (NASDAQ:CLDX)
12:27 La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Celldex Therapeutics (NASDAQ:CLDX), Alcon (NYSE:ALC)
11:44 Stifel reiterates Buy rating on Celldex stock despite EoE setback
11:28 H.C. Wainwright reiterates Buy rating on Eupraxia Pharmaceuticals stock
11:24 Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Color Star Tech (NASDAQ:ADD), Aspen Insurance Hldgs (NYSE:AHL)
11:14 Celldex stock price target lowered to $62 at Canaccord on EoE program halt
10:52 Celldex stock price target lowered to $42 by H.C. Wainwright
10:46 Celldex stock falls as Wells Fargo cuts price target on EOE trial failure
20:05 Celldex’s mast cell therapy fails to improve eosinophilic esophagitis
21:55 Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
20:22 Celldex Therapeutics earnings beat by $0.01, revenue fell short of estimates
12:13 scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
09:11 Jasper Therapeutics stock holds Market Outperform rating at JMP despite setback
11:27 Celldex stock price target maintained at $50 by H.C. Wainwright
15:00 Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
16:58 Crude Oil Rises 6%; US Consumer Sentiment Surges In June - Senmiao Tech (NASDAQ:AIHS), Chanson International (NASDAQ:CHSN)
14:33 Celldex shares jump on impressive skin disorder drug data
14:32 Visa, Mastercard lead Friday’s market cap stock movers
14:11 Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday - Bunge Global (NYSE:BG), AleAnna (NASDAQ:ANNA)
11:56 Celldex stock maintains Overweight rating on promising CSU therapy results
22:12 Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025
11:34 Celldex stock rating reiterated at Buy by Canaccord ahead of data release
20:12 Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress

Daily Range

21.71 23.02

Year Range

14.40 46.90

Previous Close: 22.38
Open: 22.52

Bid: 22.08
Ask: 22.38

Low: 21.71
High: 23.02

Volume: 2.143 K

Daily Change: -1.34%
Month Change: 1.24%

6 Months Change: 3.81%
Year Change: -45.82%

30 August, Saturday